Coloplast A/S (OTCMKTS:CLPBY) Short Interest Update

Coloplast A/S (OTCMKTS:CLPBY) saw a significant decrease in short interest in October. As of October 15th, there was short interest totalling 62,800 shares, a decrease of 14.3% from the September 30th total of 73,300 shares. Based on an average trading volume of 115,100 shares, the short-interest ratio is currently 0.5 days.

Coloplast A/S Stock Performance

Shares of Coloplast A/S stock opened at $12.75 on Thursday. The business’s fifty day simple moving average is $13.31 and its 200 day simple moving average is $12.85. The company has a current ratio of 0.85, a quick ratio of 0.56 and a debt-to-equity ratio of 1.00. Coloplast A/S has a 12 month low of $9.90 and a 12 month high of $14.34. The firm has a market capitalization of $27.54 billion, a P/E ratio of 38.64, a price-to-earnings-growth ratio of 3.30 and a beta of -0.02.

Coloplast A/S (OTCMKTS:CLPBY) last announced its earnings results on Tuesday, August 20th. The company reported $0.08 earnings per share (EPS) for the quarter. The firm had revenue of $993.49 million during the quarter. Coloplast A/S had a return on equity of 31.39% and a net margin of 18.89%. As a group, analysts anticipate that Coloplast A/S will post 0.34 EPS for the current year.

Coloplast A/S Company Profile

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Care segments.